Inherent Biosciences
Inherent Biosciences uses a next-generation sequencing and AI platform to commercialize epigenetic biomarkers for human complex disease, beginning with male infertility.
Inherent Biosciences uses a next-generation sequencing and AI platform to commercialize epigenetic biomarkers for human complex disease, beginning with male infertility.